Search results
26 paź 2021 · Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is a rare inherited disorder characterized by abnormal blood vessel formation in the skin, mucous membranes, and organs including the lungs, liver, and central nervous system.
1 lis 2021 · Also known as Osler-Weber-Rendu syndrome, HHT was named after 19th-century physicians William Osler, Fredrick Parker Weber, and Henri Jules Louis Marie Rendu , and the disease results in multisystemic vascular lesions, known as telangiectasias, and visceral arteriovenous malformations (AVMs).
Hereditary hemorrhagic telangiectasia, or Osler-Weber-Rendu disease, was first recognized in 1896. It is an autosomal dominant disorder with variable penetrance characterized by epistaxis, mucocutaneous telangiectases, and visceral arteriovenous malformations.
Hereditary hemorrhagic telangiectasia is a genetic disorder that causes abnormal blood vessel formation, leading to bleeding and complications in various organs.
11 maj 2021 · Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, is an autosomal dominant condition caused by a mutation in one of several genes. Within a family, there can be wide variation in expressivity and penetrance.
30 paź 2008 · Rendu-Osler-Weber disease or HHT is a multiorgan autosomal dominant disorder with high penetrance, characterized by epistaxis, mucocutaneous telangiectasis, and visceral arteriovenous malformations (AVMs).
Hereditary hemorrhagic telangiectasia (HHT) also known as Osler–Weber–Rendu disease is a rare autosomal dominant, multi-organ disorder characterized by the presence of multiple telangiectasias which represent arteriovenous malformations (AVMs) causing recurrent bleedings and anemia.
